Journal of Pathology Informatics (Dec 2024)

Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges

  • Marie Brevet,
  • Zaibo Li,
  • Anil Parwani

Journal volume & issue
Vol. 15
p. 100343

Abstract

Read online

For the past 2 decades, pathologists have been accustomed to reporting the HER2 status of breast cancer as either positive or negative, based on HER2 IHC. Today, however, there is a clinical imperative to employ a 3-tier approach to interpreting HER2 IHC that can also identify tumours categorised as HER2-low. Meeting this need for a finer degree of discrimination may be challenging, and in this article, we consider the potential for the integration of computational approaches to support pathologists in achieving accurate and reproducible HER2 IHC scoring as well as outlining some of the practicalities involved.

Keywords